Skip to main content
. 2017 Mar 13;39(3):244–251. doi: 10.1590/1516-4446-2016-1993

Table 3. Associations between changes in outcomes (BMI and GAF) from baseline and sociodemographic and clinical characteristics.

BMI (difference from baseline) GAF (difference from baseline)
Variable Mean (SD) ANOVA p-value Mean (SD) ANOVA p-value
Sex
    Female -0.1 (1.6) 0.037* 0.4 (7.2) 0.859
    Male -0.8 (1.3) 0.3 (5.5)
Marital status
    Married -1.0 (0.5) 0.143 -2.4 (14.7) 0.448
    Single -0.5 (0.2) 0.9 (5.2)
    Divorced 0.3 (0.5) 0.5 (4.5)
Diagnosis
    Schizophrenia/schizophrenic disorder -0.4 (1.4) 0.611 0.8 (5.7) 0.486
    Schizoaffective disorder -0.3 (1.7) -1.4 (10.2)
Variable Correlation p-value Correlation p-value
Age -0.15 0.194 0.17 0.106
Age at illness onset -0.02 0.922 -0.09 0.356
Duration of illness 0.25 0.026* 0.20 0.184
Metabolic risk index (difference from baseline) 0.23 0.033* -0.15 0.282

ANOVA = analysis of variance; BMI = body mass index; GAF = Global Assessment of Functioning; SD = standard deviation.

*

p < 0.05.